Benitec Biopharma (BNTC)
(Real Time Quote from BATS)
$11.40 USD
-0.13 (-1.09%)
Updated Aug 6, 2025 10:56 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Benitec Biopharma Limited has a market cap of $302.54M, which represents its share price of $11.53 multiplied by its outstanding shares number of 26.25M. As a small-cap company, BNTC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BNTC 11.40 -0.13(-1.09%)
Will BNTC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTC
Is Cintas (CTAS) Stock Outpacing Its Business Services Peers This Year?
Are Basic Materials Stocks Lagging Harmony Gold (HMY) This Year?
BNTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Ardagh Metal Packaging (AMBP) Stock Outpacing Its Industrial Products Peers This Year?
Is Root (ROOT) Stock Outpacing Its Finance Peers This Year?
Are Utilities Stocks Lagging CenterPoint Energy (CNP) This Year?
Other News for BNTC
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Benitec Biopharma management to meet virtually with Piper Sandler
BNTC: Upcoming Virtual Meeting by Piper Sandler | BNTC Stock News
Benitec Biopharma management to meet virtually with Piper Sandler
Benitec Biopharma (BNTC) Moves Forward with Clinical Study Enrollment | BNTC Stock News